Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
326 INR | -0.81% | -0.62% | -17.52% |
Sales 2024 * | 18.19B 218M | Sales 2025 * | 20.18B 242M | Capitalization | 30.29B 363M |
---|---|---|---|---|---|
Net income 2024 * | 1.07B 12.86M | Net income 2025 * | 1.65B 19.77M | EV / Sales 2024 * | 1.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.5 x |
P/E ratio 2024 * |
27.8
x | P/E ratio 2025 * |
18.4
x | Employees | 6,000 |
Yield 2024 * |
0.61% | Yield 2025 * |
0.71% | Free-Float | 34.22% |
Latest transcript on Indoco Remedies Limited
1 day | -0.81% | ||
1 week | -0.62% | ||
Current month | -0.82% | ||
1 month | -3.93% | ||
3 months | -12.56% | ||
6 months | +0.91% | ||
Current year | -17.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 27/04/27 | |
Pramod Ghorpade
DFI | Director of Finance/CFO | - | 02/21/02 |
Chairman | 85 | 02/63/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 85 | 02/63/02 | |
Director/Board Member | 63 | 01/82/01 | |
Chief Executive Officer | 54 | 27/04/27 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 326 | -0.81% | 157 522 |
26/24/26 | 328.6 | +1.40% | 42,066 |
25/24/25 | 324 | -1.50% | 191,638 |
24/24/24 | 329 | -0.14% | 87,448 |
23/24/23 | 329.4 | +0.44% | 46,917 |
Delayed Quote NSE India S.E., April 29, 2024 at 05:10 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.52% | 363M | |
+26.66% | 661B | |
+27.25% | 566B | |
-6.42% | 352B | |
+20.46% | 332B | |
+2.49% | 283B | |
+13.74% | 231B | |
+5.15% | 200B | |
-9.08% | 195B | |
-4.97% | 145B |
- Stock Market
- Equities
- INDOCO Stock